Here are the late-breaking trials and other key study presentations from the 2018 EuroPCR conference.
Heart Valve Technology
This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve replacement (TMVR), transcatheter and surgical valve repairs, ad surgical replacement valves.
-
-
Edwards Lifesciences Corp.announced that it received CE Mark for the Edwards Cardioband Tricuspid Valve Reconstruction System for the treatment of tricuspid regurgitation. The Cardioband Tricuspid...
-
While there is fear by many about the trend of hospitals consolidating into larger healthcare systems, one advantage might be faster matriculation of new cardiovascular technologies from flagship...
-
Patient selection for who is best suited for a transcatheter aortic valve replacement (TAVR) procedure is...
Technology | Annuloplasty Rings | June 15, 2018
June 15, 2018 — LivaNova PLC announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its...
An angiography image showing the catheter-based implantation of the Cardioband annuloplasty ring using corkscrew shaped anchors.
News | Heart Valve Technology | June 13, 2018
June 13, 2018 — Henry Ford Hospital is one of 17 U.S. trial sites using a...
The Emboliner Embolic Protection Catheter is designed to capture debris released from the valve and vessel walls during transcatheter aortic valve replacement (TAVR) procedures. It allows for the passage of other catheters during TAVR procedures.
News | Embolic Protection Devices | June 07, 2018
June 7, 2018 — The first clinical cases have been completed where the Emboliner...
News | Heart Valve Technology | June 01, 2018
June 1, 2018 – Use of the Abbott Portico transcatheter aortic valve replacement (TAVR) therapy was associated with...
Feature | EuroPCR | May 31, 2018
Here are the late-breaking trials and other key study presentations from the 2018 EuroPCR conference. This is the...
News | Heart Valve Technology | May 25, 2018
May 25, 2018 — Abbott announced favorable outcomes from the first 100 patients treated in a...
A 3-D printed aortic root with an simulated implant of an Edwards Sapien TAVR valve. New clinical data points to length-of-stay as a new predictor of outcomes in TAVR patients. Image from Henry Ford Hospital.
Feature | Heart Valve Technology | May 14, 2018
May 14, 2018 – A new study finds patients who stay in the hospital for more than 72 hours when undergoing trans-...
The use of 3-D printed hearts from patients' pre-TAVR planning CT scans have improved outcomes of procedures at the University of Minnesota. Clearly identifying where calcium is located on the valves prior to TAVR device implantation has helped reduce the incidence of paravalvular leak.
News | Heart Valve Technology | May 14, 2018
May 14, 2018 – A new study examines the effectiveness of 3-D printing technology and computer modeling to predict...
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients...
News | Heart Valve Technology | May 11, 2018
May 11, 2018 — A new study looked at the effectiveness of a novel risk tool to predict 30-day readmission rates in...
News | Heart Valve Technology | May 11, 2018
May 11, 2018 — Medtronic plc announced two-year outcomes for the Harmony...
A MitraClip device being deployed to clasp together the leaflets of the mitral valve. This mimics a surgical suture repair to create a double orifice valve with better leaflet coaptation to prevent mitral regurgitation.
News | Structural Heart | May 11, 2018
May 11, 2018 — The post-approval study evaluating the safety and efficacy of MitraClip in a real-world, commercial...
News | Heart Valve Technology | May 07, 2018
May 7, 2018 — Colibri Heart Valve LLC announced the Colibri...
A 3-D echo view of a Neovasc Tiara transcatheter mitral valve. This valve is currently in clinical trials and is ahead of most of the TMVR devices in development.
Feature | Heart Valve Technology | May 04, 2018 | Dave Fornell, Editor
May 4, 2018 — Transcatheter...
News | Heart Valve Technology | May 01, 2018
May 1, 2018 — Edwards Lifesciences Corp.announced that it received CE Mark for the Edwards Cardioband Tricuspid...
